Answers are grounded in this paper and cite their sources.
Comparative analysis demonstrates consistent low radial artery occlusion rates for distal radial access across trials and registries, supporting feasibility in routine practice.
Background Distal radial access (DRA) has emerged as an alternative to conventional transradial access (TRA) for percutaneous coronary procedures, with potential advantages for reducing radial artery occlusion (RAO). Aim To assess whether favorable outcomes observed in randomized trials are consistently reproduced in routine clinical practice. Methods A structured comparative analysis was performed between the largest randomized controlled trial of DRA (DISCO RADIAL; 650 patients, 16 centers, strict selection criteria, experienced operators) and the largest real‐world DRA registry (KODRA; 4977 consecutive patients, 14 centers, broader inclusion criteria, heterogeneous operator experience). Access‐related outcomes were summarized using inverse variance–weighted estimates and analyzed using random‐effects models to assess agreement across clinical settings, with absolute differences as the primary measure. Heterogeneity (I 2 ) was reported descriptively. Results Despite marked differences in study design, patient populations (body surface area 2.0 vs. 1.7 m 2 ), and operator experience (100% vs. 70% with ≥ 100 DRA cases), concordance was remarkable. RAO at discharge was 0.18% (95% CI 0.07%–0.29%, I 2 = 0%). Overall crossover occurred in 6.8% (95% CI 6.1%–7.4%, I 2 = 0%), with same‐side conventional TRA as predominant bailout (4.3%). Femoral access was required in only 1.3% of cases. No serious bleeding events occurred in either study. Minor bleeding and hematoma showed considerable heterogeneity (I 2 = 80%–98%), likely reflecting differences in surveillance and practice patterns. Sensitivity analyses confirmed the stability of crossover and RAO estimates. Conclusions DRA demonstrates very low RAO rates, high procedural success, and favorable safety, with consistent performance across controlled and real‐world settings, supporting its feasibility in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
Sgueglia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: